Diabetes technology & therapeutics
The Importance of Expanding Medicare Continuous Glucose Monitoring Coverage for High-Risk Hypoglycemia.
Mary Elizabeth Patti, Grazia Aleppo, Davida Kruger, Carol J Levy, Jesse Bushman, Guillermo Umpierrez, Rodolfo J Galindo, Gregory P Forlenza, Anders L Carlson, Janet B McGill
Published: 202510.1177/15209156251396120
Abstract
Medicare's current coverage policy for continuous glucose monitoring (CGM) restricts their use to people with diabetes. This restriction is based on an older National Coverage Determination (NCD 40.2) that limits blood glucose testing to people with…
Preview only. Read the full abstract at the source